These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2864248)

  • 1. Neurohumoral vasoconstrictor systems in heart failure.
    Riegger AJ
    Eur Heart J; 1985 Jun; 6(6):479-89. PubMed ID: 2864248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.
    Riegger GA; Liebau G; Holzschuh M; Witkowski D; Steilner H; Kochsiek K
    Am J Cardiol; 1984 Feb; 53(4):614-8. PubMed ID: 6320625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of vasopressin in experimental heart failure.
    Riegger AJ
    Eur Heart J; 1988 Jun; 9 Suppl H():7-10. PubMed ID: 3049096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin and angiotensin II contribute equally to the increased afterload in rabbits with heart failure.
    Arnolda L; McGrath BP; Johnston CI
    Cardiovasc Res; 1991 Jan; 25(1):68-72. PubMed ID: 2054832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurohumoral axis in congestive heart failure.
    Francis GS; Goldsmith SR; Levine TB; Olivari MT; Cohn JN
    Ann Intern Med; 1984 Sep; 101(3):370-7. PubMed ID: 6147109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin and renin in high output heart failure of rats: hemodynamic effects of elevated plasma hormone levels.
    Riegger GA; Liebau G; Bauer E; Kochsiek K
    J Cardiovasc Pharmacol; 1985; 7(1):1-5. PubMed ID: 2580126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.
    Creager MA; Faxon DP; Cutler SS; Kohlmann O; Ryan TJ; Gavras H
    J Am Coll Cardiol; 1986 Apr; 7(4):758-65. PubMed ID: 3514728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohumoral mechanisms involved in congestive heart failure.
    Francis GS
    Am J Cardiol; 1985 Jan; 55(2):15A-21A. PubMed ID: 2857062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.
    Riegger GA; Kochsiek K
    Am J Cardiol; 1986 Aug; 58(3):300-3. PubMed ID: 3526857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit.
    Arnolda L; McGrath BP; Cocks M; Johnston CI
    J Clin Invest; 1986 Sep; 78(3):674-9. PubMed ID: 3528220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nervous system control mechanisms in heart failure.
    Cohn JN
    Acta Med Scand Suppl; 1986; 707():15-20. PubMed ID: 2874690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma arginine vasopressin levels in patients with congestive heart failure.
    Goldsmith SR; Francis GS; Cowley AW; Levine TB; Cohn JN
    J Am Coll Cardiol; 1983 Jun; 1(6):1385-90. PubMed ID: 6343460
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurohumoral control mechanisms in congestive heart failure.
    Cohn JN; Levine TB; Francis GS; Goldsmith S
    Am Heart J; 1981 Sep; 102(3 Pt 2):509-14. PubMed ID: 6115571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term hemodynamic effects of vasopressin V1-receptor inhibition in chronic right-sided congestive heart failure.
    Stone CK; Liang CS; Imai N; Sakamoto S; Sladek CD; Hood WB
    Circulation; 1988 Nov; 78(5 Pt 1):1251-9. PubMed ID: 3180381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
    Creager MA; Faxon DP; Weiner DA; Ryan TJ
    Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between atrial natriuretic peptide, renin system and vasopressin in heart failure.
    Riegger AJ
    Eur Heart J; 1990 Apr; 11 Suppl B():79-83. PubMed ID: 2142083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of arginine vasopressin and angiotensin II in cardiovascular responses to combined acute hypoxemia and hypercapnic acidosis in conscious dogs.
    Rose CE; Godine RL; Rose KY; Anderson RJ; Carey RM
    J Clin Invest; 1984 Aug; 74(2):321-31. PubMed ID: 6547729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.